Aquilo Capital Management as of June 30, 2023
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 13 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals (ARWR) | 17.0 | $31M | 859k | 35.66 | |
| Blueprint Medicines (BPMC) | 15.7 | $28M | 449k | 63.20 | |
| Ishares Russell 2000 Etf Tr Unit Put Option (IWM) | 15.6 | $28M | 150k | 187.27 | |
| Merus N V (MRUS) | 11.3 | $20M | 775k | 26.33 | |
| Regenxbio Inc equity us cm (RGNX) | 9.6 | $17M | 870k | 19.99 | |
| Arvinas Ord (ARVN) | 8.6 | $16M | 624k | 24.82 | |
| Kymera Therapeutics (KYMR) | 8.3 | $15M | 651k | 22.99 | |
| Silence Therapeutics Ads (SLN) | 4.0 | $7.2M | 1.3M | 5.50 | |
| Genmab A/s Sponsored Ads (GMAB) | 3.7 | $6.6M | 175k | 38.01 | |
| Argenx Se Sponsored Adr (ARGX) | 3.5 | $6.4M | 16k | 389.73 | |
| Olema Pharmaceuticals (OLMA) | 1.3 | $2.3M | 250k | 9.03 | |
| C4 Therapeutics Com Stk (CCCC) | 1.2 | $2.1M | 761k | 2.75 | |
| Pieris Pharmaceuticals | 0.3 | $547k | 3.3M | 0.17 |
